305 related articles for article (PubMed ID: 34275451)
41. Membrane fusion, potential threats, and natural antiviral drugs of pseudorabies virus.
Ye N; Feng W; Fu T; Tang D; Zeng Z; Wang B
Vet Res; 2023 May; 54(1):39. PubMed ID: 37131259
[TBL] [Abstract][Full Text] [Related]
42. Porcine IFITM1 is a host restriction factor that inhibits pseudorabies virus infection.
Wang J; Wang CF; Ming SL; Li GL; Zeng L; Wang MD; Su BQ; Wang Q; Yang GY; Chu BB
Int J Biol Macromol; 2020 May; 151():1181-1193. PubMed ID: 31743714
[TBL] [Abstract][Full Text] [Related]
43. Pseudorabies virus (PRV) strain with defects in gE, gC, and TK genes protects piglets against an emerging PRV variant.
Lin J; Li Z; Feng Z; Fang Z; Chen J; Chen W; Liang W; Chen Q
J Vet Med Sci; 2020 Jun; 82(6):846-855. PubMed ID: 32336701
[TBL] [Abstract][Full Text] [Related]
44. Antiviral effectiveness of butylated hydroxytoluene against pseudorabies (Aujeszky's disease) virus in cell culture, mice, and swine.
Pirtle EC; Sacks JM; Nachman RJ
Am J Vet Res; 1986 Sep; 47(9):1892-5. PubMed ID: 3021025
[TBL] [Abstract][Full Text] [Related]
45. Porcine ISG15 modulates the antiviral response during pseudorabies virus replication.
Liu H; Li S; Yang X; Wang X; Li Y; Wang C; Chen L; Chang H
Gene; 2018 Dec; 679():212-218. PubMed ID: 30201339
[TBL] [Abstract][Full Text] [Related]
46. Resistance to pseudorabies virus infection in transgenic mice expressing the chimeric transgene that represses the immediate-early gene transcription.
Ono E; Tasaki T; Kobayashi T; Taharaguchi S; Nikami H; Miyoshi I; Kasai N; Arikawa J; Kida H; Shimizu Y
Virology; 1999 Sep; 262(1):72-8. PubMed ID: 10489342
[TBL] [Abstract][Full Text] [Related]
47. Hydroquinone inhibits PRV infection in neurons in vitro and in vivo.
Fang L; Gao Y; Lan M; Jiang P; Bai J; Li Y; Wang X
Vet Microbiol; 2020 Nov; 250():108864. PubMed ID: 33007606
[TBL] [Abstract][Full Text] [Related]
48. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
[TBL] [Abstract][Full Text] [Related]
49. Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant.
Zhao Y; Wang LQ; Zheng HH; Yang YR; Liu F; Zheng LL; Jin Y; Chen HY
Mol Cell Probes; 2020 Oct; 53():101605. PubMed ID: 32464159
[TBL] [Abstract][Full Text] [Related]
50. Recombinant Pseudorabies Virus (PRV) Expressing Firefly Luciferase Effectively Screened for CRISPR/Cas9 Single Guide RNAs and Antiviral Compounds.
Tang YD; Liu JT; Fang QQ; Wang TY; Sun MX; An TQ; Tian ZJ; Cai XH
Viruses; 2016 Mar; 8(4):90. PubMed ID: 27043610
[TBL] [Abstract][Full Text] [Related]
51. The full-length microRNA cluster in the intron of large latency transcript is associated with the virulence of pseudorabies virus.
Wang X; Zhang MM; Yan K; Tang Q; Wu YQ; He WB; Chen HC; Liu ZF
Virology; 2018 Jul; 520():59-66. PubMed ID: 29777914
[TBL] [Abstract][Full Text] [Related]
52. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes.
Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J
BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529
[TBL] [Abstract][Full Text] [Related]
53. Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo.
Lv C; Liu W; Wang B; Dang R; Qiu L; Ren J; Yan C; Yang Z; Wang X
Antiviral Res; 2018 Nov; 159():55-62. PubMed ID: 30266338
[TBL] [Abstract][Full Text] [Related]
54. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
[TBL] [Abstract][Full Text] [Related]
55. The effects of viral load on pseudorabies virus gene expression.
Tóth JS; Tombácz D; Takács IF; Boldogkoi Z
BMC Microbiol; 2010 Dec; 10():311. PubMed ID: 21134263
[TBL] [Abstract][Full Text] [Related]
56. Suppression of the interferon-mediated innate immune response by pseudorabies virus.
Brukman A; Enquist LW
J Virol; 2006 Jul; 80(13):6345-56. PubMed ID: 16775323
[TBL] [Abstract][Full Text] [Related]
57. The ICP22 protein selectively modifies the transcription of different kinetic classes of pseudorabies virus genes.
Takács IF; Tombácz D; Berta B; Prazsák I; Póka N; Boldogkői Z
BMC Mol Biol; 2013 Jan; 14():2. PubMed ID: 23360468
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6.
Zheng HH; Wang LQ; Fu PF; Zheng LL; Chen HY; Liu F
Virol J; 2020 Feb; 17(1):19. PubMed ID: 32014014
[TBL] [Abstract][Full Text] [Related]
59. A case report of long-delayed diagnosis of pseudorabies virus encephalitis with endophthalmitis: lessons from metagenomic next generation sequencing.
Zhang Y; Fang L; Zhou Y; Zhang Y; Liang B; Yan C; Li L
BMC Neurol; 2023 May; 23(1):192. PubMed ID: 37194001
[TBL] [Abstract][Full Text] [Related]
60. A Comparison of Pseudorabies Virus Latency to Other α-Herpesvirinae Subfamily Members.
Chen J; Li G; Wan C; Li Y; Peng L; Fang R; Peng Y; Ye C
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
